The collaborative research programme between three Academic Institutions - University of Oxford, Imperial College London and University College of London - funded by Pfizer Inc. and Ataxia UK, will aim to find a new medicine or treatment which, if successful, can hopefully move on to clinical trials in the future.  

To read the press release from Oxford University, click here.

Posted: 31/07/15